GENEVA: Swiss drug maker Novartis AG reported a 4 percent dip in first-quarter net profits Tuesday as the cost of purchasing its remaining stake in eye care company Alcon Inc. depressed earnings.
The company earned $2.82 billion in the first quarter, down from $2.95 billion in the January-March period last year when profits were boosted by high sales of swine flu vaccine.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
